S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages

Envista (NVST) Stock Price, News & Analysis

$21.39
-0.16 (-0.74%)
(As of 03/28/2024 ET)
Today's Range
$21.24
$21.62
50-Day Range
$20.64
$24.53
52-Week Range
$20.00
$40.92
Volume
1.38 million shs
Average Volume
2.24 million shs
Market Capitalization
$3.67 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$29.60

Envista MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
38.4% Upside
$29.60 Price Target
Short Interest
Bearish
5.10% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.67
Upright™ Environmental Score
News Sentiment
1.12mentions of Envista in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
13.99%
From $1.43 to $1.63 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.54 out of 5 stars

Medical Sector

115th out of 939 stocks

Dental Equipment & Supplies Industry

2nd out of 3 stocks

NVST stock logo

About Envista Stock (NYSE:NVST)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

NVST Stock Price History

NVST Stock News Headlines

NVST Envista Holdings Corporation
Grab Your Free Bitcoin Today!
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Crypto Market Preps For Trillions Worth of Inflows!
Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.
Piper Sandler Keeps Their Hold Rating on Envista Holdings (NVST)
Envista (NVST) Q4 Earnings Miss Estimates, Margins Down
See More Headlines
Receive NVST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/07/2024
Today
3/28/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
N/A
Employees
12,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$29.60
High Stock Price Target
$45.00
Low Stock Price Target
$19.00
Potential Upside/Downside
+38.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
11 Analysts

Profitability

Net Income
$-100,200,000.00
Pretax Margin
-2.14%

Debt

Sales & Book Value

Annual Sales
$2.57 billion
Cash Flow
$2.62 per share
Book Value
$24.35 per share

Miscellaneous

Free Float
169,491,000
Market Cap
$3.67 billion
Optionable
Optionable
Beta
1.35
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

NVST Stock Analysis - Frequently Asked Questions

Should I buy or sell Envista stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Envista in the last year. There are currently 3 sell ratings, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NVST shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVST, but not buy additional shares or sell existing shares.
View NVST analyst ratings
or view top-rated stocks.

What is Envista's stock price target for 2024?

11 Wall Street research analysts have issued 12-month price targets for Envista's shares. Their NVST share price targets range from $19.00 to $45.00. On average, they predict the company's share price to reach $29.60 in the next year. This suggests a possible upside of 38.4% from the stock's current price.
View analysts price targets for NVST
or view top-rated stocks among Wall Street analysts.

How have NVST shares performed in 2024?

Envista's stock was trading at $24.06 at the start of the year. Since then, NVST shares have decreased by 11.1% and is now trading at $21.39.
View the best growth stocks for 2024 here
.

Are investors shorting Envista?

Envista saw a decrease in short interest during the month of February. As of February 15th, there was short interest totaling 8,180,000 shares, a decrease of 17.1% from the January 31st total of 9,870,000 shares. Based on an average daily trading volume, of 2,520,000 shares, the short-interest ratio is presently 3.2 days.
View Envista's Short Interest
.

When is Envista's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our NVST earnings forecast
.

How were Envista's earnings last quarter?

Envista Holdings Co. (NYSE:NVST) posted its quarterly earnings results on Wednesday, February, 7th. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.33 by $0.04. The firm had revenue of $645.60 million for the quarter, compared to analyst estimates of $638.37 million. Envista had a positive trailing twelve-month return on equity of 6.31% and a negative net margin of 3.90%. The company's quarterly revenue was down 2.3% compared to the same quarter last year. During the same period last year, the firm posted $0.52 earnings per share.

What is Amir Aghdaei's approval rating as Envista's CEO?

9 employees have rated Envista Chief Executive Officer Amir Aghdaei on Glassdoor.com. Amir Aghdaei has an approval rating of 21% among the company's employees. This puts Amir Aghdaei in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When did Envista IPO?

Envista (NVST) raised $603 million in an initial public offering on Wednesday, September 18th 2019. The company issued 26,800,000 shares at $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley served as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

Who are Envista's major shareholders?

Envista's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.02%), Vanguard Group Inc. (10.01%), Dimensional Fund Advisors LP (3.79%), Massachusetts Financial Services Co. MA (3.32%), Franklin Resources Inc. (3.07%) and Nuance Investments LLC (2.29%). Insiders that own company stock include Amir Aghdaei, Curt W Bludworth, Curt W Bludworth, Eric Conley, Howard H Yu, Jeffrey Kappler, Mark E Nance, Mark E Nance, Mischa Reis and Stephen Keller.
View institutional ownership trends
.

How do I buy shares of Envista?

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NVST) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners